Literature DB >> 22458858

Overdose deaths demand a new paradigm for opioid rotation.

Lynn R Webster1, Perry G Fine.   

Abstract

OBJECTIVE: An increasing number of deaths have been inferred to be associated with current opioid rotation practices and evidence is mounting that the use of widely accepted protocols for opioid rotation is an important contributing factor. Based on the findings of a literature review published in conjunction with this article, we propose a new paradigm for a potentially safer method of opioid rotation and present a case study illustrating the paradigm. This new paradigm suggests three easy-to-remember steps in opioid rotation and obviates the need to use a conversion table.
DESIGN: Report of a clinical case of a patient undergoing opioid rotation using this new paradigm.
SUMMARY: The patient was successfully rotated from extended-release oxycodone to extended-release hydromorphone. The dose of oxycodone was slowly decreased, while the hydromorphone dose was slowly titrated. A critical element to this approach involved providing sufficient immediate-release opioid to treat breakthrough pain and to reverse acute abstinence signs and symptoms if the dosing changes prove insufficient.
CONCLUSION: A safer new paradigm for opioid rotation may provide an important incremental step forward in reducing adverse public health consequences of inappropriate opioid dosing. Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22458858     DOI: 10.1111/j.1526-4637.2012.01356.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  8 in total

1.  The opioid rotation ratio of hydrocodone to strong opioids in cancer patients.

Authors:  Akhila Reddy; Sriram Yennurajalingam; Hem Desai; Suresh Reddy; Maxine de la Cruz; Jimin Wu; Diane Liu; Eden Mae Rodriguez; Jessica Waletich; Seong Hoon Shin; Vicki Gayle; Pritul Patel; Shalini Dalal; Marieberta Vidal; Kimberson Tanco; Joseph Arthur; Kimmie Tallie; Janet Williams; Julio Silvestre; Eduardo Bruera
Journal:  Oncologist       Date:  2014-10-23

2.  Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids.

Authors:  Akhila Reddy; Sriram Yennurajalingam; Kalyan Pulivarthi; Shana L Palla; Xuan Wang; Jung Hye Kwon; Susan Frisbee-Hume; Eduardo Bruera
Journal:  Oncologist       Date:  2012-12-13

Review 3.  Toward a systematic approach to opioid rotation.

Authors:  Howard S Smith; John F Peppin
Journal:  J Pain Res       Date:  2014-10-17       Impact factor: 3.133

Review 4.  Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts.

Authors:  Mark Edmund Rose
Journal:  Pain Med       Date:  2018-04-01       Impact factor: 3.750

Review 5.  Practical management of opioid rotation and equianalgesia.

Authors:  Erwan Treillet; Sophie Laurent; Yacine Hadjiat
Journal:  J Pain Res       Date:  2018-10-29       Impact factor: 3.133

6.  Impact of Patient-Controlled Analgesia (PCA) Smart Pump-Electronic Health Record (EHR) Interoperability with Auto-Documentation on Chart Completion in a Community Hospital Setting.

Authors:  Tina M Suess; John W Beard; Barbara Trohimovich
Journal:  Pain Ther       Date:  2019-07-26

Review 7.  Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain.

Authors:  Tracy L Skaer
Journal:  J Pain Res       Date:  2014-08-19       Impact factor: 3.133

8.  The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development.

Authors:  Jeffrey Fudin; Jacqueline Pratt Cleary; Michael E Schatman
Journal:  J Pain Res       Date:  2016-03-23       Impact factor: 3.133

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.